LTR,
I had the fortune of being treated at City of Hope, in their labs they've created many drugs which they've licensed to BP's, like Herceptin. I didn't mean that every hospital could produce DCVax-L, but there are a number of such research institutions who could do so, and do it very successfully if the company wished to have spread out distribution.
I'm sure you're right about the average hospital, but in L.A. alone I suspect that three or four other major hospitals and research institutions would be capable as well. We know UCLA is doing it, but I also believe that USC and Cedars have similar capabilities as well. If I'm right about a centralized computer tied to NWBO would be controlling the EDEN unit, I believe the chance of errors could be greatly reduced. Again I'm not saying it could be done everywhere, but I don't believe distributed processing is impossible.
Not every pharmacy is a compounding pharmacy, but those that are do a good job of making certain drugs. I believe certain hospitals or laboratories that already have cryogenic capacity as well as distribution would be capable of doing the job. I'm not saying this is what the company should do, I just believe that it may be one possibility. It's very possible that such capability is completely unnecessary. I believe CRL is probably capable of supplying most of the world if that's NWBO's choice, along with Sawston serving the UK and perhaps most of Europe. Of course with sufficient funding NWBO could do it themselves, as Biotech believes, or a BP could partner with NWBO and take over the task. Personally I believe it's very different from what BP's are used to doing, so I really don't know that they'd want to take on such a task.
Gary
Bullish
